NCT07529769 2026-04-14AID-OraLAssistance Publique - Hôpitaux de ParisNot yet recruiting5,000 enrolled
NCT07502027 2026-03-30A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction AdenocarcinomaHuazhong University of Science and TechnologyPhase 4 Not yet recruiting55 enrolled